Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001493152-21-022220

Options or other derivatives

  • Chief Executive Officer acquired 225,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Trieu Vuong Chief Executive Officer 2021-09-03 Grant or award · Stock Options +225,000 225,000 D: show line 1 in the form
Loading xslF345X03/ownership.xml…